Randomized Trial of an Alternate Human Papillomavirus Vaccine Administration Schedule in College-Aged Women

Abstract

For all HPV vaccine types, the GMT ratios indicated noninferiority of the alternate vaccine administration schedule at 0, 2, and 12 months. The alternate schedule may be used to expand options for the timing of the third dose in the HPV vaccine schedule.